
Meditrax S 500mg/250mg Injection
Marketer
Medicant Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Meditrax S 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under a physician's guidance. Complete the prescribed regimen; premature cessation may compromise effectiveness. Missed doses should be avoided. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt emergency care. Inform your doctor of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, a nutritious diet, and sufficient hydration are crucial for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment efficacy.
Primary Ingredients of Meditrax S 500mg/250mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Meditrax S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Meditrax S 500mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Meditrax S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Meditrax S 500mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Meditrax S 500mg/250mg Injection works:
Ceftriaxone/Sulbactam injection (Meditrax S 500mg/250mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Meditrax S 500mg/250mg Injection's concurrent use with alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Meditrax S (500mg/250mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Meditrax S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Meditrax S 500mg/250mg Injection could induce drowsiness, blurred vision, or dizziness. Operation of a vehicle should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Meditrax S 500mg/250mg Injection's use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Meditrax S 500mg/250mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician before administering. Dosage alteration for Meditrax S 500mg/250mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Meditrax S 500mg/250mg Injection :
Should you inadvertently skip a Meditrax S 500mg/250mg Injection, seek medical advice from your physician.
Facts to Know About Meditrax S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
